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LETTERS TO THE EDITORS 
Lack of precision of duplex scan velocity 
measurements can falsely elevate rates of progression 
of carotid stenosis 
To the Editors: 
Serial duplex scanning has become almost exclusively 
used to determine rates of restenosis after carotid 
endarterectomy and the progression of stenosis in unoper-
ated carotid arteries. I have become increasingly concerned 
that the lack of precision of duplex scans (possibly coupled 
with intra-observer variability) results in an overestimation 
of the rates of progression of carotid stenosis when analyzed 
with actuarial techniques, such as the Kaplan-Meier 
method. The precision, not accuracy, of an instrument is the 
variability of repeated measurements of the same subject by 
the same observer. When sharp cutoff velocity values or 
velocity ratios are used to separate ranges of degree of 
carotid stenosis, such as <50% from ;:::50%, forward survival 
analysis of sequential measurements can result in an erro-
neous rate of progression as the result of duplex scan impre-
cision. For example, in a recent publication, the calculated 
annualized rate of progression of carotid stenosis was 9.3% 
per year for 7 years.1 The authors report the reproducibili-
ty of duplex scan results for the same level of stenosis to be 
92% for 48 carotid arteries studied within 1 month. This 
means that four of the 48 had a different finding and per-
haps half or 4% had a higher or progression value. How 
much of the 9.3% per year was caused by lack of precision 1 
A similar recent analysis indicated a 5.3% per year carotid 
artery stenosis progression rate.2 Unfortunately, few studies 
report the precision of the duplex scanning equipment used 
or the intra-observer variability. I am unaware of either 
recognition or of attempts to prevent or correct for impre-
cision when applying this type data to a survival analysis. 
Precision for my office duplex scanner. For 81 
unoperated internal carotid arteries measured within 8 
weeks by the same technician with an Ultra Mark 9 scanner 
(ATL, Bothell, Wash), I found a mean absolute difference 
between two peak systolic velocity (PSV) measurements of 
17.S cmls and a mean absolute percent difference oflS.l% 
(range, 45 to 281 cmls; mean, 123 cm/s). This is similar 
to a recently reported intra-observer difference of 13.6% for 
PSV in 20 carotid arteries. 3 Linear regression of my data for 
the standard deviation (SD) of the difference in two PSV 
measurements versus PSV gives a SD of 9.0 ± 0.12 PSV 
cm/s. For example, this regression equation predicts that a 
PSV of 130 cm/s has a SD of 24.6 cm/s and a 9S% confi-
dence interval of 81 to 179 cm/ s for the next measurement. 
If ISO cml s is used as a cutoff between <SO% stenosis and 
;:::SO% stenosis, there is an 18% chance that the next mea-
surement will be ISO cm/s or more. 
Theoretic prediction of future peak systolic velocity 
values when the measured current value is less than 150 
cm/s. I used this precision data to theoretically predict 
what would happen to 600 carotid arteries with actual initial 
PSV measurements less than ISO cm/s (101 ± 24.S cmls, 
mean ± 1 SD). All initial values were measured by the same 
technologist with the office machine. Subsequent measure-
ments are predicted by Vi = Vo + SD x ND cmls, where i = 
1 is 6 months, i = 2 is 1 year, i = 3 is 2 years, i = 4 is 3 years 
etc, Vo is the initial actual measurement, SD is the precision 
standard deviation, and ND is the normal distribution. 
These measurements were computed with JMP version 3.1 
statistical software (SAS Instituted, Cary, NC). Kaplan-Meier 
analysis predicts, for a SD of IS cm/s and a cutoff of 150 
em/sec or more for progression to ;:::SO% stenosis, a S.5% 
theoretical (erroneous) rate of progression at 6 months, a 
cumulative rate at 1 year of 8.2%, 10.3% at 2 years, 12.7% at 
3 years, and 14.7% at 4 years. The 4-year annualized rate is 
3.9% per year-all erroneous and caused by imprecision of 
PSV measurements. If a precision SD of20 cm/s is used, the 
4-year theoretic rate of progression is S.S% per year. When 
the previous regression equation for SD is used, the 4-year 
rate of progression is 4.2% per year. The erroneous rates of 
progression decrease as more samples of the same initial 
velocity values are added because of the forward deletion of 
values that exceed the cutoff in the survival analysis. These 
examples of erroneous carotid stenosis progression because 
of lack of duplex scan precision suggest that our current 
information on both the rates of progression of carotid 
stenoses and the recurrent stenosis afrer endarterectomy may 
be high. 
This is a two-way street. An initial measurement is not 
necessarily a true one and has the same lack of precision as 
later ones. Initial velocity values above a cutoff value may 
drop below it on future testing. Forward actuarial analysis 
does not account for this. However, this variability may 
come into play in a similar way when analyzing for regres-
sion of stenosis. 
One way to reduce the precision SD is to take repeated 
measurements at the same study period, but this is probably 
not economically feasible. Another approach is to define the 
precision of the scanner and technologist and correct the 
Kaplan-Meier curves accordingly. I do not know how to do 
this, but it is probably not too difficult. The bad news is that 
early restenosis or progression rates are probably significant-
ly overestimated because only two, three, or four sequential 
studies have been done. The good news is that the effect of 
imprecision dampens out the more studies are done (longer 
times), and late data is probably much more accurate. 
Joseph P. Archie, Jr, MD 
Carolina Cardiovascular Surgical Associates 
Raleigh, NC 
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24/41/99464 
Regarding "Occluding aortic endoluminal stent graft 
combined with extra-anatomic axillofemoral bypass 
as alternative management of abdominal aortic 
aneurysms for patients at high risk with complex 
anatomic features: A preliminary report" 
To the Editors: 
To assess the usefulness of this report by Le Minh and 
colleagues (J Vasc Surg 1998;28:651-6), more informa-
tion on the patient selection is necessary. Simply having a 
short proximal neck (with no data on measurements) is 
now not a contraindication to endovascular repair of 
abdominal aortic aneurysms with either an anatomic bifur-
cated graft or the less anatomic aorta uni-iliac graft, espe-
cially with the use of uncovered suprarenal stents that take 
the attachment zone away from the seal zone. 
No information has been given for the diameter of the 
endoluminal graft/occluder introducer sheath. This was 
not a percutaneous procedure. If the occluding graft can be 
positioned just below the renal arteries, this implies that the 
vessels were not that tortuous. Therefore, why not simply 
deploy an aorta urn-iliac endovascular graft with a patent 
lumen. The extra anatomic bypass graft is therefore much 
shorter (ie, a femorofemoral crossover graft rather than an 
axillofemoral graft). 
Finally, no information is given as to the length of the 
procedure. Sick patients have a high mortality after long 
operations. 
Given these criticisms I can see no place for this tech-
nique in this endovascular era. 
Stuart Walker, FReS (Eng) 
Loughborough, Leicestershire 
United Kingdom 
24/41/99466 
Reply 
We have read with interest the comments of Dr Stuart 
Walker_ 
Concerning the abdominal aortic aneurysm (AAA) 
proximal neck in our series, the average length was 12 ± 3 
mm (range, 5 to 25 mm), associated with an angulation 
from 0 degrees to 95 degrees (mean, 62 degrees). Short 
proximal neck «20 mm) associated or not to marked 
angulation has been shown to cause dislodgments of the 
stent graft followed by proximalleaks.l,2 
We agree that the use of uncovered suprarenal stents 
may prevent proximal endoleaks. However, in the study 
by Wain et al, l there were 21 % of endoleaks, despite the 
placing of proximal uncovered stents near or across the 
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renal arteries among patients with AAA treated with 
endovascular grafts. 
As mentioned in our article, the endoluminal graft 
introducer sheath had a diameter of 18F (internal diame-
ter 18F; length, 600; Balt Co. Montmarency, France) and 
was introduced on a super stiff guidewire via a femoral 
artery cut down. 
Tortuosity of iliac arteries does not preclude correct 
placing of the proximal part of the endograft beneath the 
renal arteries. In our experience, marked tortuosity of cal-
cified iliac arteries may provoke a kinking of the distal part 
of the endograft, resulting in cigar-shape formation with 
subsequent stenosis and thrombosis of the device_ 
The average length of time needed to implant the 
stent graft was 120 ± 30 minutes. The total length of the 
procedure (including axillofemoral bypass grafting) was 
175 ± 34 minutes. 
We emphasize the fact that this procedure is reserved 
for patients at high risk with short or angulated proximal 
neck associated or not with tortuous iliac arteries to ensure 
total exclusion of the AAA. 
Thuc Le Minh, MD 
Jean-Pierre Dereumc, MD 
Brussels, Belgium 
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24/41/99465 
Regarding "Percutaneous transluminal angioplasty 
for the treatment of limb threatening ischemia: Do 
the results justify an attempt before bypass grafting?" 
To the Editors: 
We read with interest the article by Parsons et al (J 
Vase Surg 1998;28:1066-71). The conclusions drawn by 
this article, namely that percutaneous transluminal angio-
plasty (PTA) is not considered to be a primary treatment 
in patients with infrainguinal disease and limb-threatening 
ischemia, should, we think, be qualified. 
The authors point out that the published reports of 
infrainguinal PTA in patients with threatened limbs have 
shown a range of results, with I-year patency ranging from 
12% to 70%. Our paper, which has been quoted in the arti-
cle1 actually shows a 24-month symptomatic patency rate of 
77% and a hemodynamic patency rate of 78%: The paper 
also quotes from our article that only 23% of all the critical-
ly ischemic patients were treated with percutaneous translu-
minal angioplasty. This indeed was true of the data that 
were collected between 1988 and 1991. We would like to 
refer you to our subsequent publications in which data was 
collected during a I-year period (1994)_2 A prospective 
